USA / Pharma Innovation Factsheet 2020
In a recent article for PharmaBoardroom, Objective Capital’s David Crean took a look at the state of US…
AMERICAS
USA / The Long Read: Innovation, Access & Affordability
A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly…
USA / FDA Drug Approvals 2020
In 2020, the US FDA’s Center for Drug Evaluation & Research (CDER) approved 53 novel drugs, up from 48 in…
Canada / The Evolution of Medical Cannabis Legislation
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical cannabis industry in Canada, its…
USA / Securing the Conditions to Secure Our Meds
The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar have on US healthcare today and…
USA / Is Its Innovation Leadership Position At-Risk?
David H. Crean, managing director for Objective Capital Partners, provides insights on US innovation and long term…
USA / NORD Chief Strategy Officer on Health Equity's Vital Importance for Rare Disease Patients
With Rare Disease Day coming up on February 28th, one of the leading organizations dedicated to serving affected…
Mexico / US Vaccine Tourism; CanSino Stepping Up; AMLO Calls for UN Intervention
The latest from Mexico’s fight against COVID-19, including news of vaccine tourism into the US, how China’s…
USA / 5 Rare Disease Start-Ups to Watch
Following on from our profile on five of the most promising clinical-stage biotech companies developing orphan…
In Conversation
Peter Marks – Director, Center for Biologics Evaluation and Research (CBER), US FDA
Dr Peter Marks MD, PhD, director of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), highlights the Center’s contributions related to the regulatory science behind vaccine development, including vaccines to prevent COVID-19; the Center’s efforts to facilitate the advancement of the field of gene therapy; as well as his commitment to following…
Latest Reports
Focus on Canada
The Evolution of Medical Cannabis Legislation in Canada
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical…
Has the Time Truly Come for Trudeau’s ‘National…
As the only country in the world to boast a universal healthcare system that…
Read more from Canada >>
Focus on Colombia
Colombian Tecnoquimicas’ USD 200 Million Manufacturing…
Tecnoquimicas (TQ), the largest domestic player in Colombia’s USD 4.6 billion…
Colombia: The Great Indian Investment Wave
With the onset of universal public healthcare, new types of foreign actors have…
Read more from Colombia >>
Focus on Brazil
Brazilian Pharma: Market Outperforming LatAm, Vaccine…
The Brazilian pharma market outperformed the Latin American average in Q1 of…
Top 5 Brazilian Pharma Companies
Six of the top ten companies in the Brazilian pharma market are domestic.* Read…
Read more from Brazil >>
Focus on Puerto Rico
New Puerto Rico Pharma Report January 2020 Out Now
Puerto Rico had to rebuild itself – in many cases quite literally – after…
Company Spotlight: Puerto Rico’s Quality &…
When life sciences companies decide to transfer the production of new drug to…
Read more from Puerto Rico >>
Focus on USA
NORD Chief Strategy Officer on Health Equity’s Vital…
With Rare Disease Day coming up on February 28th, one of the leading…
Securing the Conditions to Secure Our Meds
The AAM’s Dan Leonard highlights the savings impact that generic and…
Read more from USA >>
Focus on Mexico
Mexico: US Vaccine Tourism; CanSino Stepping Up; AMLO Calls…
The latest from Mexico’s fight against COVID-19, including news of vaccine…
Mexico Looks to India to Bolster Domestic Supply Chain…
COVID-19 has highlighted the importance of secure regional pharma supply chains…
Read more from Mexico >>
Talent / Mexican Pharma: Where Are They Now?
Between 2015 and 2017 PharmaBoardroom met with pharma country managers in Mexico who spoke about the challenges and…
USA / Takeda’s Ramona Sequeira Talks “Culture as Strategy”
After five years with Takeda heading up the Japan-headquartered pharma company’s US business, following the…
Brazil / Six Trends in the OTC Market Post-COVID-19
Panorama Faramceutico’s editorial team look at how the ongoing COVID-19 pandemic stands to affect Brazil’s over…
USA / Navigating Increasingly Stormy Market Access Waters
Certara’s Ulrich Neumann examines some of the major US market access trends of the past few years, including…
Manufacturing / Romark: Heading the New Wave of Puerto Rican Pharma Manufacturing
Headquartered in Tampa, Florida, Romark focuses on developing innovative treatments for infectious diseases and the…
Top 10 / Pharma Companies in Mexico
A compilation of the top 10 pharmaceutical companies in the Mexican pharmaceutical market based on IQVIA data from…